A transgenic mouse model for inducible and reversible dysmyelination

Journal of Neuroscience

Volumn 20, Issue 20, 2000, Pages 7698-7705

  Mathis, C ^a   Hindelang, C ^a   LeMeur, M ^a   Borrelli, E ^a  

^a INSTITUT DE GÉNÉTIQUE ET DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

Author keywords

CNS; HSV1 TK; Inducible dysmyelination; MBP promoter; Oligodendrocyte; Transgenic

Indexed keywords

FIALURIDINE; MYELIN BASIC PROTEIN; NUCLEOSIDE DERIVATIVE; THYMIDINE KINASE;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTOSIS; CONTROLLED STUDY; DEATH; ELECTRON MICROSCOPY; GENE INDUCTION; GROWTH RETARDATION; HERPES SIMPLEX VIRUS 1; IMMUNOHISTOLOGY; MOUSE; MYELIN DEFICIENCY; NONHUMAN; NORTHERN BLOTTING; OLIGODENDROGLIA; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; SEIZURE; TRANSGENE; TRANSGENIC MOUSE; TREMOR; WESTERN BLOTTING;

EID: 0034667678     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.20-20-07698.2000     Document Type: Article

References (52)

1. Purification of mouse immunoglobin heavy chain messenger RNAs total myeloma tumor RNA
2. Gliogenesis depends on glide/gem through asymmetric division of neuroglioblasts
3. Demyelination of the superior cerebellar peduncle in the mouse induced by cuprizone
4. Targeting of an inducible toxic phenotype in animal cells
5. Transgenic mice with inducible dwarfism
6. Fulminant jejuno-ileitis following ablation of enteric glia in adult transgenic mice
7. Leukocyte infiltration, neuronal degeneration, and neurite outgrowth after ablation of scar-forming, reactive astrocytes in adult transgenic mice
8. Platelet-derived growth factor delays oligodendrocyte differentiation and axonal myelination in vivo in the anterior medullary velum of the developing rat
9. Molecular biology of myelin proteins from the central nervous system
10. Structure and developmental regulation of Golli-mbp, a 105-kilobase gene that encompasses the myelin basic protein gene and is expressed in cells in the oligodendrocyte lineage in the brain
11. Developmental regulation of myelin basic protein expression in mouse brain
12. Regional and developmental variations of GFAP and actin mRNA levels in the CNS of jimpy and shiverer mutant mice
13. A role for oligodendrocytes in the stabilization of optic axon numbers
14. The role of oligodendrocytes and myelin on axon maturation in the developing rat retinofugal pathway
15. Molecular profile of reactive astrocytes - Implications for their role in neurologic disease
16. Myelin acquisition in the central nervous system of the mouse revealed by an MBP-Lac Z transgene
17. The proliferation of mature oligodendrocytes in vitro is stimulated by basic fibroblast growth factor and inhibited by oligodendrocyte-type 2 astrocyte precursors
18. The proximal region of the MBP gene promoter is sufficient to induce oligodendroglial-specific expression in transgenic mice
19. Myelin basic protein gene contains separate enhancers for oligodendrocyte and Schwann cell expression
20. Myelin mutants: Model systems for the study of normal and abnormal myelination
21. The effect of injections of lysophosphatidyl choline into white matter of the adult mouse spinal cord
22. GFAP immunoreactivity reveals astrogliosis in females heterozygous for jimpy
23. Mitosis-specific phosphorylation of histone H3 initiates primarily within pericentromeric heterochromatin during G2 and spreads in an ordered fashion coincident with mitotic chromosome condensation
24. Thymidine kinase obliteration: Creation of transgenic mice with controlled immune deficiency
25. Heterogeneity among astrocytes in reactive gliosis
26. Transgenic systems in studying myelin gene expression
27. Glial cell degeneration and hypomyelination caused by overexpression of myelin proteolipid protein gene
28. Restoration of myelin formation by a single type of myelin basic protein in transgenic shiverer mice
29. Genetic dysmyelination models
30. Developmental expression of glial fibrillary acidic protein and glutamine synthetase mRNAs in normal and jimpy mice
31. Reactive astrocytes: A review
32. Experimental strategies to promote central nervous system remyelination, in multiple sclerosis: Insights gained from the Theiler's virus model system
33. Neurological mouse mutants and the genes of myelin
34. Gene organization and transcription of duplicated MBP genes of myelin deficient (shi mld) mutant mouse
35. Pelizaeus-Merzbacher disease: A valine to phenylalanine point mutation in a putative extracellular loop of myelin proteolipid
36. Myelin deficient mice: Expression of myelin basic protein and generation of mice with varying levels of myelin
37. Development of oligodendrocytes and Schwann cells studied with a monoclonal antibody against galactocerebroside
38. The dysmyelinating mouse mutations shiverer (shi) and myelin deficient (shimld)
39. Premature arrest of myelin formation in transgenic mice with increased proteolipid protein gene dosage
40. The use of lead citrate at high pH as an electron opaque stain in electron microscopy
41. Oligodendroglial progenitor cells but not oligodendroglia divide during normal development of the rat cerebellum
42. Reactive astrocytes: Cellular and molecular cues to biological function
43. Targeted ablation of secretin-producing cells in transgenic mice reveals a common differentiation pathway with multiple enteroendocrine cell lineages in the small intestine
44. Central nervous system demyelination and remyelination in multiple sclerosis and viral models of disease
45. Antiproliferative role of dopamine: Loss of D2 receptors causes hormonal dysfunction and pituitary hyperplasia
46. Oligodendroglia regulate the regional expansion of axon caliber and local accumulation of neurofilaments during development independently of myelin formation
47. The genetics of myelin
48. Multiple sclerosis: A coordinated immunological attack against myelin in the central nervous system
49. Analysis of transcription control elements of the mouse myelin basic protein gene in HeLa cell extracts: Demonstration of a strong NFI-binding motif in the upstream region
50. Dysmyelination in transgenic mice resulting from expression of class I histocompatibility molecules in oligodendrocytes
51. Demyelination and remyelination in the rat central nervous system following ethidium bromide injection
52. Transgenic mouse model for central nervous system demyelination